Accutar Biotech
✓ Verified
Healthcare AI
AI-enabled drug discovery
Series B
Accutar Biotech is a U.S.-based, clinical-stage AI-enabled drug discovery company focused on using artificial intelligence and a hybrid computational-plus-wet-lab workflow to accelerate drug design, optimization, and development of clinically differentiated medicines.
Company Details
- Website
- accutarbio.com
- Headquarters
- Cranbury, New Jersey, United States
- Founded
- 2015
- Funding
- Over $100M
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring